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WS1.5 The use of bedside ultrasonography to identify delayed gastric
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Objectives: The gastric emptying rate (GER) may be delayed in CF, but its
assessment is problematic and previous CF studies have employed scintigraphic
techniques which are expensive and unsuitable for routine use. We wished to assess
the use of ultrasonography for this purpose, which has been validated in a non-CF
population using a 3.5-MHz abdominal transducer probe measuring gastric antral
size [1].
Methods: After an overnight fast, in the supine position we looked at 12 non-
diabetic subjects (mean age 26 [SD 4] years, 9 male) comparing the GER in
8 pancreatic insufﬁcient CF patients with 4 healthy controls. Subjects consumed
113mls (made up to 200mls with water) of Polycal®, a liquid energy supplement.
Ultrasound measurements were made regularly over 2 hours and gastric emptying
>63% at 90 minutes was considered normal.
Results: There was a signiﬁcant decrease in GER at 90 minutes (p = 0.04) and 120
minutes (p = 0.02) in the CF group (see table).
Conclusions: Delayed gastric emptying occurs in pancreatic insufﬁcient patients
with CF and without known cystic-ﬁbrosis related diabetes. The novel use of bedside
ultrasound in this patient group will allow timely management of patients with
gastro-paresis by dietary manipulation or prokinetic therapy.
Gastric Emptying Rate (%) [Median (IQ range)]
Group 30 minutes 60 minutes 90 minutes 120 minutes
Control 39 (36−43) 49 (47−52) 68 (67−70) 75 (74−76)
CF 26 (18−40) 40 (37−47) 49 (47−63) 64 (62−72)
p value 0.16 0.23 0.04 0.02
Reference(s)
[1] Darwiche G et al. J Ultrasound Med. 1999;18:673–682.
WS1.6 The need of an appropriate diagnosis of gastroesophageal
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Objectives and Study: The use of proton pump inhibitors (PPI) is diffuse among
Cystic Fibrosis (CF) patients to treat fat malabsorption and/or Gastro-esophageal
Reﬂux Disease (GERD).
The aim of this prospective study was to assess an early diagnosis of GERD and
the appropriate use of PPI in CF patients.
Methods: We enrolled CF patients aged 4 years and older, taking chronic PPI
therapy or asymptomatic for typical GERD symptoms but showing a progressive
lung deterioration.
All patients underwent pH-multichannel intraluminal impedance (pH-MII). GERD
patients underwent upper endoscopy and gastric scintigraphy labelled with 99mTc-
DTPA to study the esophageal transit and the gastric emptying.
Results: Since October 2010, 31 consecutive CF patients (female 19, mean age
20.1 yrs, range: 6−45) were enrolled. Eleven children did not take PPI therapy
because they were symptom-free.
pH-MII detected GERD in 22/31 (71%) patients; all patients with severe GERD
started PPI therapy, including 9/11 (82%) patients without typical GERD symptoms.
PPI therapy was stopped in 5/31 patients (16.1%) with negative pH-MII and also in
3/31 patients (9.7%) with mild GERD and without symptoms. Gastric scintigraphy
was performed in 17/22 (77%) GERD patients and showed a delayed esophageal
transit and gastric emptying in 8/17 (47%) and 12/17 (70.6%) patients, respectively.
Two patients (2/22) with severe esophagitis and pathologic scintigraphy underwent
surgery.
Conclusion: GERD management was changed in more than 60% of patients. Our
results underline the need of a correct diagnostic algorithm for GERD in CF patients
to allow an appropriate treatment.
WS1.7 Gastroesophageal reﬂux in adult cystic ﬁbrosis: a primary
phenomenon or secondary to respiratory dysfunction?
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Leuven, Translational Research Center for Gastrointestinal Disorders, Leuven,
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It has been suggested that gastroesophageal reﬂux (GER) in CF is a primary
phenomenon, since reﬂux occurs already at young age. Reﬂux occurs mostly during
transient lower esophageal sphincter relaxations (TLESR). We showed that reﬂux
during TLESR is mostly due to an increased gastroesophageal pressure gradient
(GEPG), caused by decreased intra-thoracic pressures (ITP).
We aimed to assess the relation between magnitude of respiratory oscillations and
GER in CF.
Methods: 12 CF adults and 11 age and sex-matched healthy subjects were studied
using high resolution manometry-impedance. In the thorax, expiration provokes
slightly positive pressure that becomes negative in inspiration, which is opposite
in the abdomen. GEPG was calculated by subtracting ITP from intra-abdominal
pressure (IAP).
Results: GEPG in expiration was similar in CF and healthy. However, GEPG was
signiﬁcantly higher in CF patients compared to healthy subjects during inspiration
[13.1 (9.9–15.8) vs. 7.1 (4.5−9.4)mmHg, p = 0.005]. This was due to signiﬁcantly
lower ITP in CF [−7.5 (−10.6 − (−5.6)) vs. 0.07 (−6−1.1)mmHg, p = 0.003]. In CF,
77 (67−85)% of the reﬂux episodes started during inspiration vs. 23 (15−33)%
in expiration (p< 0.0001). In healthy subjects, reﬂux occurred in both respiratory
phases.
Conclusion: CF patients have reﬂux during TLESR due to high GEPG which was
caused by decreased thoracic pressures. This is particularly signiﬁcant during the
inspiratory phase of respiratory oscillations. Most TLESR-related reﬂux in CF starts
in inspiration. The increased inspiratory effort in CF can favor reﬂux suggesting
that in CF adults reﬂux can be a secondary phenomenon to respiratory dysfunction.
WS1.8 Risks of PPI treatment in patients with cystic ﬁbrosis: effect
of gastric juice of patients “on” PPI on IL-8 production by CF
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Patients with CF are often treated with proton pump inhibitors (PPI) to reduce acidic
gastroesophageal reﬂux (GER). Duodeno-gastric aspiration is common in CF. We
showed that gastric juice (GJ) from patients “on” PPI can induce high IL-8 levels
by bronchial epithelial cells, mainly related to increased bacterial sub-products.
We aimed to evaluate the effect of GJ “on” PPI on IL-8 production by CF primary
bronchial epithelial cells (CF-PBEC) and compare this with healthy PBEC (H-
PBEC).
Methods: PBEC, obtained at lung transplantation were stimulated with GJ “off”
PPI (1/1000) and GJ “on” PPI (1/1000). IL-8 levels were measured in supernatant.
Results: GJ “off” PPI provoked lower IL-8 production than GJ “on” PPI, both
in H-PBEC [11.4 (4.2–28.1) vs. 462.9 (200.3–1468) pg/ml, p = 0.0001] as in CF-
PBEC [85.2 (25.6–131.2) vs. 1468 (841.4–2449) pg/ml, p< 0.0001]. Exposure of
cells to GJ “off” PPI and “on” PPI provoked higher IL-8 production in CF-PBEC
compared to H-PBEC [“off” 85.2 (25.6–131.2) vs. 11.4 (4.2–28.1) pg/ml, p = 0.02;
“on” 1468 (841.4–2449) vs. 462.9 (200.3–1468) pg/ml, p = 0.04]. Filtration of the
GJ “on” PPI reduced IL-8 production, both in H-PBEC as in CF-PBEC. There
was a correlation between IL-8 and the pH of GJ, both in H-PBEC (r = 0.66) as in
CF-PBEC (r = 0.73).
Conclusion: CF patients, treated with PPI, have non-acidic GJ and bacterial
contamination and often do aspirate. The aspirated material has an enhanced
inﬂammatory effect on CF-PBEC. Our data suggest that chronic PPI treatment
in CF may result in a paradoxically increased inﬂammatory effect in the airways.
Alternative anti-reﬂux therapies should be considered in CF with increased GER
and demonstrated aspiration.
